JP2017531678A5 - - Google Patents

Download PDF

Info

Publication number
JP2017531678A5
JP2017531678A5 JP2017522086A JP2017522086A JP2017531678A5 JP 2017531678 A5 JP2017531678 A5 JP 2017531678A5 JP 2017522086 A JP2017522086 A JP 2017522086A JP 2017522086 A JP2017522086 A JP 2017522086A JP 2017531678 A5 JP2017531678 A5 JP 2017531678A5
Authority
JP
Japan
Prior art keywords
group
alkyl
substituted
groups
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017522086A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017531678A (ja
JP6616412B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/074431 external-priority patent/WO2016062790A1/en
Publication of JP2017531678A publication Critical patent/JP2017531678A/ja
Publication of JP2017531678A5 publication Critical patent/JP2017531678A5/ja
Application granted granted Critical
Publication of JP6616412B2 publication Critical patent/JP6616412B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017522086A 2014-10-23 2015-10-22 Nik阻害剤としての新規のピラゾロピリミジン誘導体 Expired - Fee Related JP6616412B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14190073 2014-10-23
EP14190073.8 2014-10-23
PCT/EP2015/074431 WO2016062790A1 (en) 2014-10-23 2015-10-22 New pyrazolopyrimidine derivatives as nik inhibitors

Publications (3)

Publication Number Publication Date
JP2017531678A JP2017531678A (ja) 2017-10-26
JP2017531678A5 true JP2017531678A5 (enExample) 2019-11-21
JP6616412B2 JP6616412B2 (ja) 2019-12-04

Family

ID=51846471

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017522086A Expired - Fee Related JP6616412B2 (ja) 2014-10-23 2015-10-22 Nik阻害剤としての新規のピラゾロピリミジン誘導体

Country Status (13)

Country Link
US (2) US10221180B2 (enExample)
EP (1) EP3209663B1 (enExample)
JP (1) JP6616412B2 (enExample)
KR (1) KR102523405B1 (enExample)
CN (1) CN107074882B (enExample)
AU (1) AU2015334915B2 (enExample)
BR (1) BR112017007704B1 (enExample)
CA (1) CA2960574C (enExample)
EA (1) EA033237B1 (enExample)
ES (1) ES2715104T3 (enExample)
IL (1) IL251778B (enExample)
MX (1) MX371152B (enExample)
WO (1) WO2016062790A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI663166B (zh) 2013-04-24 2019-06-21 健生藥品公司 新化合物
TWI627173B (zh) 2013-09-26 2018-06-21 比利時商健生藥品公司 作為NIK抑制劑的新穎3-(1H-吡唑-4-基)-1H-吡咯并[2,3-c]吡啶衍生物
TWI704146B (zh) 2013-09-26 2020-09-11 比利時商健生藥品公司 用作NIK抑制劑之新的1-(4-嘧啶基)-1H-吡唑並[3,2-c]吡啶衍生物
EA033238B1 (ru) 2014-10-23 2019-09-30 Янссен Фармацевтика Нв Новые производные тиенопиримидина в качестве ингибиторов nik
CN107074855B (zh) 2014-10-23 2019-11-05 詹森药业有限公司 作为nik抑制剂的新的化合物
ES2704749T3 (es) 2014-10-23 2019-03-19 Janssen Pharmaceutica Nv Nuevos derivados de pirazol en calidad de inhibidores de nik
KR102523405B1 (ko) 2014-10-23 2023-04-18 얀센 파마슈티카 엔.브이. Nik 억제제로서의 신규 피라졸로피리미딘 유도체
CN112839648B (zh) 2018-06-07 2025-04-04 达萨玛治疗公司 Sarm1抑制剂
ES2992431T3 (es) * 2018-06-18 2024-12-12 Janssen Pharmaceutica Nv Derivados de pirazol como inhibidores de MALT1
EP3897670A4 (en) 2018-12-19 2022-09-07 Disarm Therapeutics, Inc. MRSA1 INHIBITORS IN COMBINATION WITH NEUROPROTECTIVE AGENTS
WO2020203950A1 (ja) * 2019-03-29 2020-10-08 興和株式会社 新規アザインドール誘導体
SMT202400418T1 (it) 2019-05-31 2024-11-15 Janssen Pharmaceutica Nv Inibitori a piccola molecola di chinasi che induce nf-κb

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990007926A1 (en) * 1989-01-20 1990-07-26 Pfizer Inc. 3-(1,2,5,6-tetrahydropyridyl)-pyrrolopyridines
BRPI0510319A (pt) 2004-04-26 2007-10-16 Pfizer inibidores da enzima integrase de hiv
AR056786A1 (es) 2005-11-10 2007-10-24 Smithkline Beecham Corp Compuesto de 1h- imidazo ( 4,5-c) piridin-2-ilo, composicion farmaceutica que lo comprende, procedimiento para preparar dicha composicion, su uso para preparar unmedicamento, uso de una combinacion que omprende al compuesto y al menos un agente antineoplasico para preparar un medicamento y dicha com
DE102008005493A1 (de) 2008-01-22 2009-07-23 Merck Patent Gmbh 4-(Pyrrolo[2,3-c] pyridine-3-yl)-pyrimidin-2-yl-amin-derivate
WO2009158011A1 (en) 2008-06-26 2009-12-30 Amgen Inc. Alkynyl alcohols as kinase inhibitors
JP2011526931A (ja) 2008-07-03 2011-10-20 エグゼリクシス, インコーポレイテッド Cdkモジュレーター
WO2010042337A1 (en) 2008-10-07 2010-04-15 Merck Sharp & Dohme Corp. Novel 6-azaindole aminopyrimidine derivatives having nik inhibitory activity
CN101723936B (zh) 2008-10-27 2014-01-15 上海睿星基因技术有限公司 激酶抑制剂及其在药学中的用途
WO2011050245A1 (en) 2009-10-23 2011-04-28 Yangbo Feng Bicyclic heteroaryls as kinase inhibitors
CA2827161A1 (en) 2011-03-16 2012-09-20 F. Hoffmann-La Roche Ag 6,5-heterocyclic propargylic alcohol compounds and uses therefor
TWI663166B (zh) 2013-04-24 2019-06-21 健生藥品公司 新化合物
TWI627173B (zh) 2013-09-26 2018-06-21 比利時商健生藥品公司 作為NIK抑制劑的新穎3-(1H-吡唑-4-基)-1H-吡咯并[2,3-c]吡啶衍生物
TWI704146B (zh) 2013-09-26 2020-09-11 比利時商健生藥品公司 用作NIK抑制劑之新的1-(4-嘧啶基)-1H-吡唑並[3,2-c]吡啶衍生物
EA033238B1 (ru) 2014-10-23 2019-09-30 Янссен Фармацевтика Нв Новые производные тиенопиримидина в качестве ингибиторов nik
CN107074855B (zh) 2014-10-23 2019-11-05 詹森药业有限公司 作为nik抑制剂的新的化合物
ES2704749T3 (es) 2014-10-23 2019-03-19 Janssen Pharmaceutica Nv Nuevos derivados de pirazol en calidad de inhibidores de nik
KR102523405B1 (ko) 2014-10-23 2023-04-18 얀센 파마슈티카 엔.브이. Nik 억제제로서의 신규 피라졸로피리미딘 유도체

Similar Documents

Publication Publication Date Title
JP2017531678A5 (enExample)
JP2017531677A5 (enExample)
JP2020111602A (ja) 抗がんおよび抗増殖活性を示すn−アシル−n’−(ピリジン−2−イル)尿素および類似体
JP2016531868A5 (enExample)
JP2019094345A5 (enExample)
US20170157134A1 (en) Combination therapy
JP2019524883A5 (enExample)
JP2010524932A5 (enExample)
JP2016531858A5 (enExample)
JP2014037426A5 (enExample)
JP2012510458A5 (enExample)
JP2015503540A5 (enExample)
JP2013522229A5 (enExample)
MX2010007374A (es) Nuevos derivados de c-21-ceto lupano, preparacion y uso de los mismos.
JP2019515884A5 (enExample)
JP2014506582A5 (enExample)
RU2018113718A (ru) Новые соединения
JP2019505529A5 (enExample)
JP2019535723A5 (enExample)
RU2012130929A (ru) Гетероциклические соединения в качестве ингибиторов янус-киназы
JP2024507414A (ja) ウイルス感染症治療のためのrock2阻害剤
KR101401220B1 (ko) 방사선 치료 증강제
MY206359A (en) Heteroaryl-substituted pyrazole compound and medicinal use thereof
RU2007103831A (ru) Производные пиразола
RU2015155032A (ru) Тилозиновые производные и способ их получения